Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Nov 3 - Nov 8
Amarasate has been clinically proven to reduce hunger by 30%, food cravings by 40% and calorie intake by 18%
N., Nakano K., Bartrons R., Gottlieb E., Vousden K
Dietary and Hydration Changes : Many patients modify their eating and drinking habits when starting GLP-1 therapy
However, Wegovy (semaglutide) and Saxenda (liraglutide) are approved for weight loss in kids ages 12 years and older with obesity
Orforglipron is the first small molecule GLP-1 to complete a Phase III trial, lowering A1C by an average of 1.3% to 1.6% across doses
All options are HSA/FSA eligible, no insurance required, and available nationwide
US$ 22.09
US$ 29.43
US$ 23.31
US$ 28.57
US$ 22.81
US$ 20.66
US$ 24.53
US$ 29.06
US$ 26.24
